Spero Therapeutics
(NASDAQ:SPRO)
$2.00
0.03[1.52%]
At close: Sep 30
$2.00
After Hours: 6:53PM EDT
Day Range1.89 - 2.152 Wk Range0.68 - 16.3Open / Close1.92 / 2Float / Outstanding29.8M / 35.1M
Vol / Avg.2.3M / 7.2MMkt Cap70.1MP/E-50d Avg. Price1.03
Div / Yield-Payout Ratio-Total Float29.8MEPS-0.87

Spero Therapeutics Stock (NASDAQ:SPRO), Quotes and News Summary

Spero Therapeutics Stock (NASDAQ: SPRO)

Day Range1.89 - 2.152 Wk Range0.68 - 16.3Open / Close1.92 / 2Float / Outstanding29.8M / 35.1M
Vol / Avg.2.3M / 7.2MMkt Cap70.1MP/E-50d Avg. Price1.03
Div / Yield-Payout Ratio-Total Float29.8MEPS-0.87
Sector: Health Care.Industry: Biotechnology
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-09
REV
Q2 2022Est.ActualSurprise
EPS-0.540-0.510 0.0300
REV1.150M1.993M843.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Spero Therapeutics Questions & Answers

Q
How do I buy Spero Therapeutics (SPRO) stock?
A

You can purchase shares of Spero Therapeutics (NASDAQ: SPRO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Spero Therapeutics's (SPRO) competitors?
Q
What is the target price for Spero Therapeutics (SPRO) stock?
A

The latest price target for Spero Therapeutics (NASDAQ: SPRO) was reported by HC Wainwright & Co. on Monday, September 26, 2022. The analyst firm set a price target for 6.00 expecting SPRO to rise to within 12 months (a possible 200.00% upside). 10 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Spero Therapeutics (SPRO)?
A

The stock price for Spero Therapeutics (NASDAQ: SPRO) is $2 last updated September 30, 2022, 8:00 PM UTC.

Q
Does Spero Therapeutics (SPRO) pay a dividend?
A

A quarterly cash dividend of $0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on October 7, 2015 to stockholders of record on September 16, 2015.

Q
When is Spero Therapeutics (NASDAQ:SPRO) reporting earnings?
A

Spero Therapeutics’s Q3 earnings are confirmed for Wednesday, November 9, 2022.

Q
Is Spero Therapeutics (SPRO) going to split?
A

There is no upcoming split for Spero Therapeutics.

Q
What sector and industry does Spero Therapeutics (SPRO) operate in?
A

Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.